Apurva Goswamy (CEO)
Master’s in Molecular Biology from Zurich, Ph.D. in Cell Biology from the University of Basel – has a wealth of experience in Drug Safety, Quality Management, and Biomedical Research behind him, having worked in these fields for over 31 years. He was responsible, until a few years ago, for building and heading a major CRO: one of the largest organizations in the world providing PV services, employing upwards of 2200 highly skilled scientists and physicians. Currently he heads the forward-looking CONTINUUM India as CEO and Managing Partner, and is responsible for defining the overall vision of the organization, developing strategy, and implementing operational policies. Under him, CONTINUUM provides services under several business verticals, including Pharmacovigilance, Evidence Evaluation, Regulatory and allied Technologies. Like before – when he was able to consolidate PV functions in India, US, UK, Switzerland, China and Japan; and was able to successfully serve multiple clients globally, including 6 of the top 10 Pharmaceutical companies – his company, CONTINUUM, is now poised to extend its footprint world-wide.
Dr Hitesh Sharma (VP – Operations)
Has a proven track record of over 14 years in strategic and operational leadership in driving excellence and enabling growth within the Pharmacovigilance Industry. He is a collaborative, result-oriented physician with experience in leading projects in India, Japan and China. He has successfully led large pharmacovigilance operations for top large pharmaceutical companies and is skilled in developing processes for increased quality, compliance and cost-effectiveness. He is a strong people manager and understands operations and people management, client management, continual improvement philosophy and building formidable teams. He is a Subject Matter Expert (SME) in the domain of Single case processing, Literature management, Affiliate support management and affiliate solutions.
Sahil Bansal (VP – Medical)
Has been working in the field of Pharmacovigilance for close to a decade. He is a Subject Matter Expert (SME) in the preparation of Aggregate Reports. He has played a key role in the setup of and leading project teams for large, mid and small sized pharma clients in the US, the UK and Europe, across products under development, lifecycle products, established/mature products and generic products. He has successfully deployed best practices to help clients develop highly efficient processes and workflows delivering unparalleled standard of Quality and Compliance. He is a physician with four years of clinical experience in cardiology, family medicine and community medicine.
Amrish Mehta (VP – IT Infrastructure & Security)
Has over 20 years of experience in information technology industry with variety of roles. During this period, he has amassed a wide range of experience through a variety of senior positions covering both external customer facing and internal leadership roles. He has extensive experience in Pharmacovigilance IT Systems/applications, managing IT Enterprise Infrastructure, IT Operations and IT applications including activities related to planning, IT strategy and supervision. In his present role, he plays a key role in integrating various departments/systems while streamlining processes and upgrading existing IT infrastructure standards.
Sumeet Labana (VP – Quality)
Brings with her over ten years of experience as a pharmacovigilance Quality Assurance professional, with a total experience of more than 15 years in the pharmacovigilance industry. She has been responsible for setting up and maintaining the company’s Quality Management System, a role that she had performed in her previous organization as well. With her passion for quality, excellent work ethic and willingness to walk the extra mile, she makes sure that we remain compliant with the requisite requirements for quality, enabling delivery of the high-quality services that we are known for. She has successfully hosted scores of client audits as well as supported clients during regulatory authority inspections, in addition to managing the other aspects of a standard Quality System such as CAPA system, document control, record management, internal audits, validations, trend analyzes and business continuity.
Manu Sehgal (VP – Regulatory & EES)
Has about two decades of experience in global drug development processes. She has supported several client engagements, leading to successful regulatory and reimbursement submissions. Manu has held leadership positions for US/UK based global CRO/market access companies and her rich experience spans across drugs, medical devices and consumer products in different phases of development i.e. early stage evidence planning to lifecycle management. Manu has expertize in researching, analyzing and reporting HEOR, RWE, epidemiology, efficacy, safety and QOL/PRO based evidence in oncology, autoimmune disorders, psychiatry, rare indications and pain management. She has extensive experience in building stable and high performing delivery teams for clients. Manu has contributed significant research to ISPOR (International society for Pharmacoeconomics and Outcomes Research), DIA (Session chair) and therapy area specific journals.
Neha (VP – Projects)
Is a pharmacovigilance professional with 14 years of experience in Pharmacovigilance. She is skilled in building new businesses and transforming legacy business models. Neha is a key member of the leadership team and is responsible for project set-up, smooth transition of processes until go-live deliverables, capacity planning, process management, resource management, project contract renewals, process efficiency management, training and compliance and Client Relationship Management. She has spent 13 years in various operational leadership positions working with clients in US and Europe. She has led the set-up of Medical Information Call Center and Data migration Projects for global clients. Her domain expertize is in ICSRs management and is an expert in both Human and Veterinary Drug Safety.
Howard Abroms (Director – Global Business Development)
Has over 20 years of experience in the Drug Safety arena. In the last decade, as part of the largest Drug Safety CRO in the world, he has formed partnerships with several top tier Pharmaceutical and Biotech companies, understanding and fulfilling their outsourcing strategies for Drug Safety reporting in the USA and Europe. In addition to his Business Development duties, he has spearheaded the establishment of a 24/7 call center for adverse event intake, and hired personnel in the US for escalated cases in his previous roles. He brings immense experience with his non aggressive sales style, and expert knowledge of the client’s needs and a complete understanding of each company’s unique outsourcing strategies for their Drug Safety requirements, be it ICSR’s, Aggregates, Literature Search, Call Center, Safety Database support and all affiliate services pertaining to the crucial aspects of patient Safety.